Jun Peng

Jun Peng

Auto-generated profile, based on publicly available information

Jun Peng

Department of Nephrology, People’s Hospital of Rizhao, Rizhao City, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2010 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
JPJun Peng
Jun Peng
QYQuan Yuan
Quan Yuan
BLBin Lin
Bin Lin
PPPorkodi Panneerselvam
Porkodi Panneerselvam
XWXiaowei Wang
Xiaowei Wang
JDJeak Ling Ding
Jeak Ling Ding
SARM (sterile α‐ and armadillo‐motif‐containing protein), the fifth identified TIR (Toll–interleukin 1 receptor (IL‐1R)) domain‐containing adaptors in humans, downregulates NF‐κB and IRF3 (interferon‐regulatory factor 3)‐mediated TLR3 and TLR4 signaling. SARM was characterized as a negative regulator of the TRIF (TIR‐domain‐containing adaptor protein inducing IFN‐β)‐dependent pathway via its interaction with TRIF. However, the precise mechanism of action of SARM remains unclear. Here, we demonstrate that SARM inhibits MAPK activation in human embryonic kidney 293 cells, and U937 cells. Both the TRIF‐ and MyD88‐mediated, as well as basal MAPK activity, were repressed, indicating that SARM‐mediated inhibition may not be exclusively directed at TRIF or MyD88, but that SARM may also directly inhibit MAPK phosphorylation. The MAPK inhibition effect was verified by RNAi, which increased the basal level of AP‐1. Furthermore, LPS challenge upregulated SARM at both the mRNA and protein levels. Finally, we provide evidence to show that truncated SARM changes its subcellular localization, suggesting the importance of the N‐terminal and sterile alpha motif domains in the autoregulation of SARM activity.

8 April 2021 in Inflammation
Verified
Journal Article
Closed access
PDF file
YHYan He
Yan He
YSYuanzhu Sun
Yuanzhu Sun
JPJun Peng
Jun Peng